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Posttraumatic stress disorder is a long-lasting psychiatric disease with the consequence of hippocampal
atrophy in humans exposed to severe fatal stress. We demonstrated a positive correlation between the
transient decline of 5-bromo-20-deoxyuridine (BrdU) incorporation in the hippocampal dentate gyrus
(DG) and long-lasting behavioral abnormalities in mice with traumatic stress. Here, we investigated
pharmacological properties of theanine on the declined BrdU incorporation and abnormal behaviors in
mice with traumatic stress. Prior daily oral administration of theanine at 50e500 mg/kg for 5 days
signiﬁcantly prevented the decline of BrdU incorporation, while theanine signiﬁcantly prevented the
decline in the DG even when administered for 5 days after stress. Consecutive daily administration of
theanine signiﬁcantly inhibited the prolonged immobility in mice with stress in forced swimming test
seen 14 days later. Although traumatic stress signiﬁcantly increased spontaneous locomotor activity over
30 min even when determined 14 days later, the increased total locomotion was signiﬁcantly amelio-
rated following the administration of theanine at 50 mg/kg for 14 days after stress. These results suggest
that theanine alleviates behavioral abnormalities together with prevention of the transient decline of
BrdU incorporation in the hippocampal DG in adult mice with severe traumatic stress.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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In adult mice, the extremely traumatic stress water immersion
restrain stress (WIRS) (1) induced a variety of long-lasting bidi-
rectional behavioral abnormalities, such as ﬂashback, numbing and
hyper-arousal, which are similar to the symptoms often seen in
patients with posttraumatic disorder (PTSD) (2). These bidirec-
tional abnormal behaviors were invariably prevented by a daily
intraperitoneal injection of several antidepressants (2), which were
shown to promote both proliferation and neuronal differentiation
in neural progenitor cells during adult neurogenesis (3e5). Prior
experience ofWIRS indeed led to a transient decline of 5-bromo-20-
deoxyuridine (BrdU) incorporation in proliferating cells located in
the hippocampal dentate gyrus (DG) in adult mice, in addition to
inducing bidirectional behavioral abnormalities related to numbing
and hyper-arousal. These included hyperactive spontaneousnese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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fear-conditioning test (CFS) and prolonged immobilization in a
forced swimming test (FST) (2).
Theanine (¼g-glutamylethylamide) is an amino acid ingredient
of green tea with a structural analogy to glutamine (Gln), which is
believed to be a precursor for the amino acid neurotransmitters g-
aminobutyric and glutamic acids, in the brain (6). Although a prior
intracerebroventricular injection of theanine protected hippocam-
pal CA1 pyramidal neurons against delayed neuronal cell death in
brains of gerbils with bilateral forebrain global ischemia in vivo (7),
theanine was a poor inhibitor of ligand binding to three different
neurotoxic ionotropic glutamate receptor subtypes in rat cortical
synaptic membranes in vitro (8). In contrast, theanine markedly
inhibited [3H]Gln incorporation without affecting [3H]glutamate
uptake in rat brain synaptosomal fractions and cultured rat
neocortical neurons, along with similarly active incorporation of
both [3H]theanine and [3H]Gln in a sodium- and structure-
dependent manner (9).
In cultured pluripotent P19 cells capable of proliferating for self-
renewal with an ability to subsequently differentiate into neuronal
and astroglial lineages, theanine promoted both activities to pro-
liferate for cluster formation and to differentiate into cells highly
immunoreactive for a neuronal marker protein in vitro (10).
Although similar promotion of both activities was seen in P19 cells
with stable overexpression of solute carrier 38a1
(SLC38A1 ¼ glutamine transporter) supposed to be responsible for
the transport of both Gln and theanine across cell membranes,
theanine failed to additionally facilitate the promotion of both
proliferation and neuronal differentiation in stable Slc38a1 trans-
fectants of P19 cells (10). Theanine intake was also shown to pro-
mote the object recognition memory in rats (11) and to prevent the
cognitive dysfunction in accelerated-senescence mice (12).
These previous ﬁndings prompted us to evaluate pharmaco-
logical proﬁles of theanine on the aforementioned bidirectional
behavioral abnormalities as well as decreased BrdU incorporation
in the DG in adult mice with WIRS in vivo.2. Methods
2.1. Animal use
The protocol employed here meets the guideline of the Japanese
Society for Pharmacology and was approved by the Committee for
Ethical Use of Experimental Animals at Kanazawa University
(Permit No. 70093). All efforts were made to minimize animal
suffering and to reduce the number of animals used.2.2. WIRS
Male Std-ddY mice (Japan SLC, Inc., Shizuoka, Japan) weighing
30e35 g and aged 6 weeks were bred under standard animal
housing conditions at 23 ± 1 C with humidity of 55% and a light/
dark cycle of 12 h, with free access to food and water. Animals
starved overnight were subjected to restraint stress in a metallic
cage (Natsume Seisakusho, Tokyo, Japan) immersed in water at
25 C up to the clavicle for 3 h (1). Control animals were similarly
fasted, followed by placement in unfamiliar breeding cages for 3 h.
The experimental groups were chosen by means of a completely
randomized design. Animals were orally administered with the-
anine (Tokyo Kasei Kogyo, Tokyo, Japan) at doses of 5, 50 and
500 mg/kg dissolved in phosphate-buffered saline (PBS) in a vol-
ume of 10 mL/kg body weight once a day for different periods.
Behavioral tests were invariably done 24 h after the ﬁnal oral
administration of theanine at different doses.2.3. BrdU labeling
Mice were intraperitoneally administered with BrdU at 50 mg/
kg twice for labeling cells newly synthesizing DNA, followed by
perfusion with 4% paraformaldehyde (PA) 12 h after the second
injection and subsequent dissection of coronal sections with a
thickness of 40 mm in a Leica cryostat at 20 C for immunohis-
tochemical analysis of incorporated BrdU. Every ﬁfth coronal
section was invariably collected between the stereotaxic
coordinates 1.88 mm and 6.04 mm posterior to bregma ac-
cording to the procedures described previously (13, 14). Sections
were denatured in 50% formamide at 65 C for 2 h, and in 2 M HCl
at 37 C for 30 min (13). Sections were then incubated in 0.1 M
boric acid (pH 8.5) for 10 min, followed by immunohistochemistry
(IHC) for BrdU using an anti-BrdU antibody (1:200). The number
of BrdU-immunoreactive cells was counted in the subgranular
zone and the hilus in the DG as shown in Supplemental Fig. S1
according to the procedures described previously (2, 14).
Filtering criteria were applied to exclude small BrdU-positive
particles with a diameter less than 1 mm2 and linear immuno-
stained objects. The number of cells in a cluster was calculated by
dividing the size of clusters by the average size of single BrdU-
positive cells. A cell-cluster was deﬁned as an object greater
than or equal to twice the average size of single BrdU-positive cells
(about 4e5 mm2).2.4. Behavioral analysis
The procedure for CFT consisted of two phases: conditioning
and testing. For the cued fear-conditioning phase, mice were
subjected to WIRS under the sound of metronome (YAMAHA,
Shizuoka, Japan) set at ‘allegro’ for 3 h. Control mice were exposed
to the tone alone for 3 h in a plastic cage. Mice were habituated to
the test cage for 5 min without the tone various days after
WIRS, followed by exposure to the tone alone for 15 min to
determine the freezing response. Freezing behavior was deﬁned as
immobility for 10 consecutive seconds with the exception of
respiration, with scoring every 10 s for the calculation of freezing
percentages according to the equation: freezing periods/total
periods  100.
Mice were placed in an open cylindrical container (diameter
14 cm; height 20 cm), containing water at 25 ± 1 C to 16 cm depth,
and forced to swim for 10 min as a FST. Each mouse was judged to
be immobile when it ceased struggling and remained ﬂoating
motionless in the water, making only those movements necessary
to keep its head above water. All animals were ﬁrst matched ac-
cording to the results of immobility, and then divided into three
groups. On the next day, each group of animals was subjected to
WIRS. On the day of the assessment, mice were placed in water for
10 min and the duration of immobility was measured as described
above.
On Day 14 after WIRS, spontaneous locomotor activity was
measured in a transparent acrylic cage (25 cm 25 cm 20 cm) for
30 min using digital counters with an infrared sensor (Neurosci-
ence Idea Inc., Osaka, Japan) as described previously (15).2.5. Data analysis
All results are expressed as the mean ± SE, and the statistical
signiﬁcance was determined by the one-way or two-way ANOVA
with Bonferroni/Dunnett's post hoc test. The level of signiﬁcance
was set at p < 0.05.
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3.1. BrdU incorporation into DG
As WIRS for 3 h was shown to transiently decrease BrdU
incorporation in the DG (2), adult micewere administered theanine
at different doses for 5 days, followed by WIRS for 3 h and subse-
quent determination of BrdU incorporation in the DG 5 days later.
Prior administration of theanine at 5 mg/kg failed to signiﬁcantly
affect the declined incorporation of BrdU in mice with WIRS, while
that of theanine at 50 and 500 mg/kg signiﬁcantly prevented the
decline in the numbers of total and clustered cells incorporating
BrdU in the DG when determined 5 days after WIRS (Fig. 1). Ani-
mals were next subjected to WIRS for 3 h, followed by daily
administration of 50 mg/kg theanine for 5 days after WIRS along
with 2 injections of BrdU at an interval of 12 h on Day 4. Although
theanine alone did not signiﬁcantly affect the number of BrdU-
positive cells within the DG in mice not subjected to WIRS, the-
anine signiﬁcantly prevented the decline in the number of total and
clustered cells incorporating BrdU in the DG when given orally at
50 mg/kg for 5 consecutive days after WIRS (Fig. 2).
3.2. Behavioral abnormalities
Micewere subjected toWIRS for 3 h together with ametronome
tone for conditioning, followed by determination of freezing
behavior induced in response to the metronome tone alone.
Although freezing behavior was drastically increased in mice with
this conditioning during exposure to the tone for 15 min 1 day or 5
days after WIRS, no signiﬁcant change in the incidence of freezing
behavior was seen in mice with oral administration of theanine at
50 mg/kg before and after WIRS (Fig. 3, left panel). Freezing
behavior in response to the tone was seen even 28 days after WIRSFig. 1. Effects of prior administration of theanine on BrdU incorporation in DG of adult mice
days, followed by exposure to WIRS for 3 h and subsequent injection of BrdU twice at a 12
number of cells labeled by BrdU was counted under a microscope on a blinded basis in 8 inde
given vehicle alone. ##p < 0.01, signiﬁcantly different from the value in mice with WIRS alo
Dunnett post hoc test.in mice conditioned, while consecutive daily administration of
theanine at 50 mg/kg failed to signiﬁcantly alleviate the increased
freezing behavior up to 28 days after WIRS (Fig. 3, right panel).
We then performed a behavioral test on FST to evaluate the
effect of theanine on a traumatic stressor associated with water.
Mice were matched to each other according to prior test results on
their immobility in water for 10 min a day before WIRS. Mice were
then subjected to WIRS, followed by FST for 10 min 14 days after
WIRS. The duration of immobility was signiﬁcantly longer in mice
previously exposed to WIRS than in mice not exposed to WIRS
(Fig. 4A). Theanine was effective in signiﬁcantly inhibiting the
prolonged immobility in mice with FST 14 days after WIRS when
administered before and after WIRS. Mice were placed in an acrylic
cage 14 days after WIRS, followed by measurement of spontaneous
locomotor activity for 30 min. Prior exposure to WIRS resulted in a
signiﬁcant increase in spontaneous locomotion determined every
5 min for 30 min compared with control animals 14 days later. The
increased total locomotion over 30 min was signiﬁcantly amelio-
rated in mice administered with theanine for 14 days after WIRS
(Fig. 4B).
4. Discussion
The essential importance of the present ﬁndings is that the
green tea ingredient theanine, which is an amino acid analogous to
Gln, prevented the decline of BrdU incorporation in the DG of mice
exposed to severe stress, with concomitant alleviation of abnormal
behaviors, when orally administered once a day after stress. In our
previous study (2), prior experience ofWIRS led to a variety of long-
lasting bidirectional behavioral abnormalities similar to the
symptoms seen in patients with PTSD, in addition to a transient
decline of BrdU incorporation in the hippocampal DG in adult mice.
The fact that several antidepressants shown to promote adultwith WIRS. Mice were administered with theanine at different doses once a day for 5
-h interval before immunohistochemical detection of BrdU on 5 days after WIRS. The
pendent experiments. **p < 0.01, signiﬁcantly different from each control value in mice
ne. Statistical signiﬁcance was determined using the one-way ANOVA with Bonferroni/
Fig. 2. Effects of later administration of theanine on BrdU incorporation in DG of adult mice with WIRS. Mice were subjected toWIRS for 3 h, followed by daily oral administration of
theanine at 50 mg/kg for 5 days and subsequent injection of BrdU twice at a 12-h interval before immunohistochemical detection on Day 5. The number of cells labeled by BrdU was
counted under a microscope on a blinded basis in 8 independent experiments. **p < 0.01, signiﬁcantly different from each control value in mice given vehicle alone. #p < 0.05,
##p < 0.01, signiﬁcantly different from the value in mice with WIRS alone. Statistical signiﬁcance was determined using the one-way ANOVA with Bonferroni/Dunnett post hoc test.
Fig. 3. Effects of consecutive administration of theanine on freezing behaviors in adult mice with WIRS. Mice were administered with theanine at 50 mg/kg once a day for 5 days,
followed by exposure to WIRS under metronome tones for 3 h and subsequent further administration of 50 mg/kg theanine for different days up to 28 days. Freezing behavior in
response to the tone alone for 15 minwas determined to enable calculation of freezing percentages according to the equation “freezing (%) ¼ freezing periods/total periods 100” in
8 separate experiments. Control mice were subjected to the metronome tone for 3 h in an unfamiliar plastic cage. **p < 0.01, signiﬁcantly different from each control value in mice
not exposed to WIRS. Statistical signiﬁcance was determined using the two-way ANOVA with Bonferroni/Dunnett post hoc test.
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Fig. 4. Effects of consecutive administration of theanine on behavioral changes in adult mice with WIRS. (A) Mice were administered theanine at 50 mg/kg for 5 days, followed by
exposure to WIRS for 3 h and subsequent further administration of 50 mg/kg theanine for 14 days to enable determination of duration of immobility on FST in 8e13 separate
experiments. (B) Mice were subjected to WIRS for 3 h, followed by oral administration of 50 mg/kg theanine once a day for 14 days, with subsequent determination of spontaneous
locomotion every 5 min for 30 min. The total counts over 30 min for 8e19 separate experiments are summed. **p < 0.01, signiﬁcantly different from each control value in mice not
exposed to WIRS. #p < 0.05, ##p < 0.01, signiﬁcantly different from the value in mice with PBS alone. Statistical signiﬁcance was determined using the one-way or two-way ANOVA
with Bonferroni/Dunnett post hoc test.
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BrdU incorporation with alleviating ﬂashbacked freezing, pro-
longed immobility and hyper-locomotion behaviors in mice with
WIRS (2), argues in favor of an idea that theanine would promote
DNA synthesis required for cell division in the DG of adult mice
toward the alleviation or treatment of depression in a particular
situation.
Taking into consideration our previous ﬁndings that WIRS failed
to prevent the decline of the number of cells immunoreactive for
neuronal nuclei and glial ﬁbrillary acidic protein when determined
21 and 28 days later under similar experimental conditions (2), it is
conceivable that severe traumatic stress, such as WIRS, would
negatively regulate self-replication of neural progenitor cells
expressed in the DG in a manner irrelevant to subsequent differ-
entiation in adult murine brains. The fact that theanine was effec-
tive even after daily oral administration for a period insufﬁcient for
cellular differentiation of neural progenitor cells in the adult DG
in vivo (2) gives support for the aforementioned irrelevance of
differentiation into a particular cell lineage with the prevention by
theanine of WIRS-induced behavioral abnormalities. The patho-
logical signiﬁcance of deteriorated proliferation activity seen in
neural progenitor cells located in the hippocampal DG of adult mice
withWIRS, however, remains to be elucidated in future studies. The
current paradoxical data on the pharmacological proﬁles of the-
anine between CFT and FST could be accounted for by taking into
consideration the role of particular brain regions in fear condi-
tioning. The memory acquired in contextual fear-conditioning such
as FST is associatedwith hippocampal functions, for example, while
the amygdale but not the hippocampus is involved in the memory
acquired in cued fear-conditioning such as CFT (17). The failure of
theanine alone to signiﬁcantly facilitate BrdU incorporation in the
DG in mice without WIRS after daily intake would be due to lessabundance of dividing neural progenitor cells located in the hip-
pocampal DG of adult mice than embryonic mice. The underlying
mechanism for the alleviation by theanine of the stress-induced
abnormal behaviors in mice with traumatic stress is yet to be
clariﬁed.
To our knowledge, this is the ﬁrst direct demonstration of the
prevention by theanine of the transient decline of BrdU incorpo-
ration in the DG together with alleviation of particular behavioral
abnormalities in adult mice previously subjected to severe trau-
matic stress. High-quality green tea leaves contain more than 2%
theanine (18), and thus people are ingesting about 20 mg of the-
anine on a daily basis, according to the estimated use of 1 g of
powdered green tea for the traditional tea ceremony in Japan.
Theanine is also known to enter the brain through the bloodebrain
barrier (19), along with a property to protect humans from a variety
of mental and physical stressors (20). Considering the high
enrichment of both caffeine and catechins rather than theanine in
green tea leaves, however, it is unlikely that the aforementioned
beneﬁts are solely mediated by the promotion by theanine of
proliferation of neural progenitor cells incorporating BrdU for self-
replication in the DG during adult neurogenesis in humans.
The fact that [3H]theanine uptake was highly sensitive to the
competitive inhibition by Gln in rat brain synaptosomes (9) un-
doubtedly gives support to the notion that theanine is a good
substrate for several Gln transporters responsible for the trans-
portation of Gln across cell membranes, rather than a ligand for a
particular glutamate receptors, in the brain. Glutamine is shown to
play a critical role in cellular proliferation in a variety of cell types
such as lymphocytes, enterocytes and tumor cells (21). In Caco-2
cells, Gln accelerated proliferation for self-renewal in association
with stimulation of nucleotide synthesis (22). Although Gln ﬂux
was shown to regulate the activity of mammalian target of
T. Takarada et al. / Journal of Pharmacological Sciences 127 (2015) 292e297 297rapamycin kinase required for translation and autophagy toward
coordination of cell growth and proliferation (23), the exact
mechanism by which theanine prevented the decline of BrdU
incorporation in dividing cells in the DG is not clear so far. Future
comparative pharmacological proﬁling between theanine and Gln
gives a clue for elucidating molecular mechanisms underlying the
prevention of declined BrdU incorporation in the DG.
It thus appears that the green tea amino acid ingredient the-
anine is beneﬁcial for preventing the deterioration of proliferation
activity for self-replication in the DG along with alleviation of
behavioral abnormalities in adult mice with severe traumatic
stress. Theanine could be a future target molecule for the discovery
and development of drugs useful for the prophylaxis and/or
treatment of patients suffering from different neurodegenerative
and neuropsychiatric diseases related to impairment of abilities of
neural progenitor cells to proliferate for self-renewal in embryonic,
developing and adult brains.Conﬂict of interest
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